Firefly Bio is a biotechnology company focused on developing new classes of payloads for Antibody-Drug Conjugates (ADCs) with the help of renowned researchers with decades of experience in ADC discovery and development.

John Flygare

Carolyn Bertozzi

Bernhard Geierstanger

Firefly Bio

Almato provides AI-enabled automation solutions through their product HIRO, which mimics human learning and knowledge application to automate processes.

Almato

Realizing the full potential of ADCs by unlocking new classes of payloads

Firefly is excited to share that we've closed a $94M Series A to advance Degrader Antibody Conjugates (DACs) that combine the unique strengths of ADCs with selective protein degraders. We're funded by Versant Ventures, MPM BioImpact, Decheng Capital, and Eli Lilly & Co. 
https://lnkd.in/grEAF9U8

Metric
Company Name	Firefly Bio	Almato
Symbol
MSH ID	COM:FIREFLYBIOLOGICS	CO:ARAGO
Market	PRIVATE	PRIVATE
Sector	8	Technology
Industry	Biotechnology	Software & IT Services
Country	US	DE
Stage	Series A
Employee Count	12	11
Website	fireflybiologics.com	arago.co
LinkedIn	firefly-biologics	arago-consulting-s-a-s
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		22.02K
Web Traffic Growth		-0.18
Valuation
Raised Capital	94M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:FIREFLYBIOLOGICS

Firefly Bio

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue